New antibiotic and method for developing it exploits microbes' natural environment
the ONA take:
Researchers have discovered a powerful new antibiotic, teixobactin, using an unusual method. Teixobactin was tested in mice and easily cured severe infections, with no side effects.
Testing in humans will not begin for approximately 2 years, according to the researchers; therefore, its safety and effectiveness are not known at this time.
Even if the drug passes all the tests, it may not be available for 5 or 6 years. Importantly, the researchers are excited about the method used to produce this antibiotic because it has the potential to lead to the discovery of more natural compounds to fight infections and cancer.
In this method, drugs are extracted from bacteria that live in dirt. The method exploits the biological antibiotics found in the natural environment—the dirt—where microbes exist.
The process involves diluting a soil sample and placing it on a specialized device. The device is then placed into a box full of the same soil the sample came from, thereby tricking the bacteria into growing into a colony in its natural environment. The method may help resolve two significant issues in global health: the increase in infections that resist commonly used drugs and the lack of new antibiotics to replace those that are no longer effective.
Researchers have discovered a powerful new antibiotic, teixobactin, using an unusual method.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|